6 Stocks Moving In Monday's After-Hours Session

Gainers:

GENFIT S A/ADR GNFT shares are up 9% after announcing a strategic partnership with Terns Pharmaceuticals to develop and commercialize elafibranor in Greater China. The company will receive an upfront payment of $35 million.

Nabriva Therapeutics PLC - ADR NBRV shares are up 3% after reporting the EMA validated the marketing authorization application for lufamulin.

Losers:

Conatus Pharmaceuticals Inc CNAT shares are down 57% after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.

Gamida Cell Ltd GMDA shares are down 10% after the company filed for a common stock offering of 4.04 million shares.

Krystal Biotech Inc KRYS shares are down 4% after filing for a $100-million common stock offering.

Mirati Therapeutics Inc MRTX shares are down 2% after reporting a common stock offering. The size was not disclosed.